Prospective Grant of Exclusive License, 14417-14418 [2011-6124]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 51 / Wednesday, March 16, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
‘‘Low Income Levels’’ Used for Various
Health Professions and Nursing
Programs Included in Titles III, VII and
VIII of the Public Health Service Act
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
The Health Resources and
Services Administration (HRSA) is
updating income levels used to identify
a ‘‘low-income family’’ for the purpose
of determining eligibility for programs
that provide health professions and
nursing training for individuals from
disadvantaged backgrounds. These
various programs are included in Titles
III, VII and VIII of the Public Health
Service Act.
The Department periodically
publishes in the Federal Register lowincome levels used to determine
eligibility for grants and cooperative
agreements to institutions providing
training for (1) disadvantaged
individuals, (2) individuals from
disadvantaged backgrounds, or (3)
individuals from ‘‘low-income’’ families.
SUPPLEMENTARY INFORMATION: The
various health professions and nursing
grant and cooperative agreement
programs that use the low-income levels
to determine whether an individual is
from an economically disadvantaged
background in making eligibility and
funding determinations generally make
awards to: Accredited schools of
medicine, osteopathic medicine, public
health, dentistry, veterinary medicine,
optometry, pharmacy, allied health
podiatric medicine, nursing,
chiropractic, public or private nonprofit
schools which offer graduate programs
in behavioral health and mental health
practice, and other public or private
nonprofit health or education entities to
assist the disadvantaged to enter and
graduate from health professions and
nursing schools. Some programs
provide for the repayment of health
professions or nursing education loans
for disadvantaged students.
SUMMARY:
jlentini on DSKJ8SOYB1PROD with NOTICES
Low-Income Levels
The Secretary defines a ‘‘low-income
family’’ for programs included in Titles
III, VII and VIII of the Public Health
Service Act as having an annual income
that does not exceed 200 percent of the
Department’s poverty guidelines. A
family is a group of two or more
individuals related by birth, marriage, or
VerDate Mar<15>2010
16:56 Mar 15, 2011
Jkt 223001
adoption who live together or an
individual who is not living with any
relatives. Most HRSA programs use the
income of the student’s parents to
compute low-income status, while a few
programs, depending upon the
legislative intent of the program,
programmatic purpose of the lowincome level, as well as the age and
circumstances of the participant, will
use the student’s family as long as he or
she is not listed as a dependent on the
parents’ tax form. Each program will
announce the rationale and choice of
methodology for determining lowincome levels in their program
guidance. The Department’s poverty
guidelines are based on poverty
thresholds published by the U.S. Bureau
of the Census, adjusted annually for
changes in the Consumer Price Index.
The Secretary annually adjusts the
low-income levels based on the
Department’s poverty guidelines and
makes them available to persons
responsible for administering the
applicable programs. The income
figures below have been updated to
reflect increases in the Consumer Price
Index through December 31, 2010.
2011 POVERTY GUIDELINES FOR THE
48 CONTIGUOUS STATES AND THE
DISTRICT OF COLUMBIA
Size of parents’ family *
1
2
3
4
5
6
7
8
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
Income
level **
$21,780
29,420
37,060
44,700
52,340
59,980
67,620
75,260
For families with more than 8
persons, add $3,820 for each additional
person.
2011 POVERTY GUIDELINES FOR
ALASKA
Size of parents’ family *
1
2
3
4
5
6
7
8
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
Income
level **
$27,200
36,760
46,320
55,880
65,440
75,000
84,560
94,120
For families with more than 8
persons, add $4,780 for each additional
peron.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
14417
2011 POVERTY GUIDELINES FOR
HAWAII
Size of parents’ family *
1
2
3
4
5
6
7
8
Income
Level **
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
..................................................
$25,080
33,860
42,640
51,420
60,200
68,980
77,760
86,540
For families with more than 8
persons, add $4,390 for each additional
person.
* Includes only dependents listed on
Federal income tax forms. Some
programs will use the student’s family
rather than his or her parents’ family.
** Adjusted gross income for calendar
year 2010.
Separate poverty guidelines figures
for Alaska and Hawaii reflect Office of
Economic Opportunity administrative
practice beginning in the 1966–1970
period. (Note that the Census Bureau
poverty thresholds—the version of the
poverty measure used for statistical
purposes—have never had separate
figures for Alaska and Hawaii.) The
poverty guidelines are not defined for
Puerto Rico or other outlying
jurisdictions. Puerto Rico or other
outlying jurisdictions shall use income
guidelines for the 48 Contiguous States
and the District of Columbia.
Dated: March 10, 2011.
Mary K. Wakefield,
Administrator.
[FR Doc. 2011–6110 Filed 3–15–11; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice of intent to grant
exclusive license.
AGENCY:
Pursuant to 35 U.S.C.
209(c)(1) and 37 CFR 404.7(a)(1)(i), this
will serve to notify the public that the
National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of
an exclusive patent license to
intellectual property broker ICAP Ocean
Tomo to promote the utilization by the
public of the inventions described in the
following U.S. patents: 7,122,624
SUMMARY:
E:\FR\FM\16MRN1.SGM
16MRN1
14418
Federal Register / Vol. 76, No. 51 / Wednesday, March 16, 2011 / Notices
entitled ‘‘PH2 Receptor Ligands’’ (HHS
Ref. No. E–123–1999/0), and 7,087,736
entitled ‘‘Tyrosine DNA
phosphodiesterases (TDP) and related
polypeptides, nucleic acids, vectors,
TDP producing host cells, antibodies
and methods of use’’ (HHS Ref. No.
E–281–1999/0). The patent rights in this
invention have been assigned to the
United States of America.
The prospective exclusive license
territory may be worldwide and the
field of use may be for the use of the
Licensed Patent Rights in developing
biopharmaceutical products.
Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before March
31, 2011 will be considered.
DATES:
Requests for copies of the
patent application, inquiries, comments,
and other materials relating to the
contemplated exclusive license should
be directed to: Mojdeh Bahar, J.D.,
Chief, Cancer Branch, Office of
Technology Transfer, National Institutes
of Health, 6011 Executive Boulevard,
Suite 325, Rockville, MD 20852–3804;
Telephone: (301) 435–2950; Facsimile:
(301) 402–0220; E-mail:
baharm@mail.nih.gov.
ADDRESSES:
Prior to
March 31, 2011, with NIH’s explicit
prior consent, ICAP will advertise the
availability of the NIH technologies for
licensing. Bidders may bid at anytime.
Before any bid is accepted, NIH will
review the commercial development
plan (CDP) and assess the suitability of
the bidder as a licensee.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless
within fifteen(15) days from the date of
this published notice, the NIH receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
jlentini on DSKJ8SOYB1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
16:56 Mar 15, 2011
Jkt 223001
Dated: March 9, 2011.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2011–6124 Filed 3–15–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
Exercise of Authority Under Section
212(d)(3)(B)(i) of the Immigration and
Nationality Act
Office of the Secretary, DHS.
Notice of determination.
AGENCY:
ACTION:
Authority: 8 U.S.C. 1182(d)(3)(B)(i).
Following consultations with the
Secretary of State and the Attorney
General, I hereby conclude, as a matter
of discretion in accordance with the
authority granted to me by section
212(d)(3)(B)(i) of the Immigration and
Nationality Act (INA), 8 U.S.C.
1182(d)(3)(B)(i), as amended, as well as
the foreign policy and national security
interests deemed relevant in these
consultations, that subsection
212(a)(3)(B)(i)(VIII) of the INA, 8 U.S.C.
1182(a)(3)(B)(i)(VIII), shall not apply,
with respect to an alien, who received
military-type training (as defined in
section 2339D(c)(1) of title 18, United
States Code) under duress from, or on
behalf of, a terrorist organization as
described in subsection 212(a)(3)(B)(vi),
8 U.S.C. 1182(a)(3)(B)(vi), provided that
the alien satisfies the relevant agency
authority that the alien:
(a) Is seeking a benefit or protection
under the INA and has been determined
to be otherwise eligible for the benefit
or protection;
(b) Has undergone and passed all
relevant background and security
checks;
(c) Has fully disclosed, to the best of
his or her knowledge, in all relevant
applications and interviews with U.S.
government representatives and agents,
the nature and circumstances of each
instance of military-type training and
any other activity or association falling
within the scope of section 212(a)(3)(B)
of the INA, 8 U.S.C. 1182(a)(3)(B);
(d) Has not received training that
itself poses a risk to the United States
or United States interests (e.g., training
on production or use of a weapon of
mass destruction, as defined by 18
U.S.C. Section 2332a(c)(2), torture, or
espionage);
(e) Poses no danger to the safety and
security of the United States; and
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
(f) Warrants an exemption from the
relevant inadmissibility provision in the
totality of the circumstances.
Implementation of this determination
will be made by U.S. Citizenship and
Immigration Services (USCIS), in
consultation with U.S. Immigration and
Customs Enforcement (ICE), or by U.S.
consular officers, as applicable, who
shall ascertain, to their satisfaction, and
in their discretion, that the particular
applicant meets each of the criteria set
forth above.
When determining whether the
military-type training was received
under duress, the following factors,
among others, may be considered:
Whether the applicant reasonably could
have avoided, or took steps to avoid,
receiving military-type training,
including whether the applicant left or
escaped the training at the earliest
opportunity, if one presented itself; the
severity and type of harm inflicted or
threatened and to whom the harm was
directed; and the perceived imminence
of the harm threatened and the
perceived likelihood that the harm
would be inflicted.
When considering the totality of the
circumstances, factors to be considered,
in addition to the duress-related factors
stated above, may include, among
others: The length and nature of the
military-type training provided; the
nature of the activities committed by the
terrorist organization; the alien’s
awareness of those activities; the alien’s
conduct since the time of the militarytype training; and any other relevant
factor.
This exercise of authority may be
revoked as a matter of discretion and
without notice at any time with respect
to any and all persons subject to it. Any
determination made under this exercise
of authority as set out above can inform
but shall not control a decision
regarding any subsequent benefit or
protection applications, unless such
exercise of authority has been revoked.
This exercise of authority shall not be
construed to prejudice, in any way, the
ability of the U.S. government to
commence subsequent criminal or civil
proceedings in accordance with U.S.
law involving any beneficiary of this
exercise of authority (or any other
person). This exercise of authority
creates no substantive or procedural
right or benefit that is legally
enforceable by any party against the
United States or its agencies or officers
or any other person.
In accordance with section
212(d)(3)(B)(ii) of the INA, 8 U.S.C.
1182(d)(3)(B)(ii), a report on the aliens
to whom this exercise of authority is
applied, on the basis of case-by-case
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 76, Number 51 (Wednesday, March 16, 2011)]
[Notices]
[Pages 14417-14418]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-6124]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive License
AGENCY: National Institutes of Health, Public Health Service, HHS.
ACTION: Notice of intent to grant exclusive license.
-----------------------------------------------------------------------
SUMMARY: Pursuant to 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i),
this will serve to notify the public that the National Institutes of
Health, Department of Health and Human Services, is contemplating the
grant of an exclusive patent license to intellectual property broker
ICAP Ocean Tomo to promote the utilization by the public of the
inventions described in the following U.S. patents: 7,122,624
[[Page 14418]]
entitled ``PH2 Receptor Ligands'' (HHS Ref. No. E-123-1999/0), and
7,087,736 entitled ``Tyrosine DNA phosphodiesterases (TDP) and related
polypeptides, nucleic acids, vectors, TDP producing host cells,
antibodies and methods of use'' (HHS Ref. No. E-281-1999/0). The patent
rights in this invention have been assigned to the United States of
America.
The prospective exclusive license territory may be worldwide and
the field of use may be for the use of the Licensed Patent Rights in
developing biopharmaceutical products.
DATES: Only written comments and/or applications for a license which
are received by the NIH Office of Technology Transfer on or before
March 31, 2011 will be considered.
ADDRESSES: Requests for copies of the patent application, inquiries,
comments, and other materials relating to the contemplated exclusive
license should be directed to: Mojdeh Bahar, J.D., Chief, Cancer
Branch, Office of Technology Transfer, National Institutes of Health,
6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804;
Telephone: (301) 435-2950; Facsimile: (301) 402-0220; E-mail:
baharm@mail.nih.gov.
SUPPLEMENTARY INFORMATION: Prior to March 31, 2011, with NIH's explicit
prior consent, ICAP will advertise the availability of the NIH
technologies for licensing. Bidders may bid at anytime. Before any bid
is accepted, NIH will review the commercial development plan (CDP) and
assess the suitability of the bidder as a licensee.
The prospective exclusive license will be royalty bearing and will
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
The prospective exclusive license may be granted unless within
fifteen(15) days from the date of this published notice, the NIH
receives written evidence and argument that establishes that the grant
of the license would not be consistent with the requirements of 35
U.S.C. 209 and 37 CFR 404.7.
Applications for a license in the field of use filed in response to
this notice will be treated as objections to the grant of the
contemplated exclusive license. Comments and objections submitted to
this notice will not be made available for public inspection and, to
the extent permitted by law, will not be released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: March 9, 2011.
Richard U. Rodriguez,
Director, Division of Technology Development and Transfer, Office of
Technology Transfer, National Institutes of Health.
[FR Doc. 2011-6124 Filed 3-15-11; 8:45 am]
BILLING CODE 4140-01-P
